Suchergebnisse - "Chan, Wah-Kheong"

PubPharm (202)

1

Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease

enthalten in: JAMA | 2024

von Lin, H. | Lee, H. | Yip, T. | +37

CommentIn: JAMA. 2024 Apr 16;331(15):1274-1275. - PMID 38512225

2

Metabolic fatty liver syndromes : where do we stand in 2024?

enthalten in: Journal of gastroenterology and hepatology | 2024

von Chan, W. | George, J.

3

Prevalence and risk factors for impaired renal function among Asian patients with nonalcoholic fatty liver disease

enthalten in: Hepatobiliary & pancreatic diseases international : HBPD INT | 2024

von Sun, C. | Goh, G. | Chow, W. | +10

4

Diagnostic accuracy of non-invasive tests to screen for at-risk MASH-An individual participant data meta-analysis

enthalten in: Liver international : official journal of the International Association for the Study of the Liver | 2024

von Mózes, F. | Lee, J. | Vali, Y. | +41

5

Machine learning improves the prediction of significant fibrosis in Asian patients with metabolic dysfunction-associated steatotic liver disease - The Gut and Obesity in Asia (GO-ASIA) Study

enthalten in: Alimentary pharmacology & therapeutics | 2024

von Verma, N. | Duseja, A. | Mehta, M. | +23

6

Correspondence : "A multisociety Delphi consensus statement on new fatty liver disease nomenclature"

enthalten in: Annals of hepatology | 2024

von Wan, K. | Chan, W. | Yusoff, M. | +4

7

Global survey of stigma among physicians and patients with nonalcoholic fatty liver disease

enthalten in: Journal of hepatology | 2024

von Younossi, Z. | Alqahtani, S. | Alswat, K. | +53

8

Machine learning improves the prediction of significant fibrosis in Asian patients with metabolic dysfunction‐associated steatotic liver disease– The Gut and Obesity in Asia (GO‐ASIA) Study

enthalten in: Alimentary Pharmacology & Therapeutics | 2024

von Verma, N. | Duseja, A. | Mehta, M. | +23

9

MAFLD fibrosis score : Using routine measures to identify advanced fibrosis in metabolic-associated fatty liver disease

enthalten in: Alimentary pharmacology & therapeutics | 2023

von Cheung, J. | Zhang, X. | Wong, G. | +12

CommentIn: Aliment Pharmacol Ther. 2023 Dec;58(11-12):1234-1235. - PMID 37986594

10

A multisociety Delphi consensus statement on new fatty liver disease nomenclature

enthalten in: Hepatology (Baltimore, Md.) | 2023

von Rinella, M. | Lazarus, J. | Ratziu, V. | +151

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[21]